Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
drug discovery
2
×
fda
ipo
2
×
life sciences
national blog main
new york blog main
new york top stories
accent therapeutics
aducanumab
agios pharmaceuticals
alzheimer's disease
amblyotech
asklepios biopharmaceutical
bioeurope
biogen
biomarin pharmaceutical
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer drugs
cara therapeutics
clinical trials
david e. shaw
deerfield management
detroit blog main
detroit top stories
drug development
enasidenib
esperion
europe blog main
europe top stories
financing
gilead sciences
immunomedics
incyte
What
ipo
medicines
2
×
activity
approvals
bio
biogen
clamped
company’s
course
covid
delays
developing
development
discover
economic
experimental
fast
fda
growing
handiwork
helped
including
internal
isn’t
landscape
lot
new
oric’s
pipeline
roundup
scan
schrödinger
schrödinger’s
sets
showing
software
spot
spread
support
testing
Language
unset
Current search:
medicines
×
ipo
×
" drug discovery "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
